Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.45
Bid: 6.10
Ask: 6.80
Change: -0.30 (-4.44%)
Spread: 0.70 (11.475%)
Open: 6.75
High: 6.75
Low: 6.45
Prev. Close: 6.75
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Feb 2017 17:25

RNS Number : 8885W
Kromek Group PLC
14 February 2017
 

14 February 2017

 

Kromek Group plc

("Kromek" or the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Further to the announcement by the Company on 10 February 2017, Sir Peter Williams, the non-Executive Chairman of the Company, has confirmed to the Company that he was allocated, and hence purchased, 14,814 ordinary shares of 1 pence each in the Company ("Ordinary Shares") as part of the open offer announced on 25 January 2017.

 

The Company has further been informed that on 13 February 2017, Sir Peter Williams bought 35,186 Ordinary Shares at a price of 22.19 pence per Ordinary Share, in the open market.

 

Following the purchases Sir Peter Williams is beneficially interested in 80,000 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.

 

The Company has also been informed that Derek Bulmer, the Chief Financial Officer of the Company, was allocated, and hence purchased, 23,934 Ordinary Shares as part of the open offer. Following the purchase Mr Bulmer is beneficially interested in 63,934 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.

 

Finally, further to the announcement made by the Company on 13 February 2017, Jerel Whittingham, a non-Executive Director, has confirmed that he has today purchased 4,440 Ordinary Shares at a price of 21.45 pence per Ordinary Share. Following his purchase Mr Whittingham is beneficially interested in 114,890 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.

 

 

Enquiries

Kromek Group plc

01740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO

 

 

 

Cenkos Securities plc

0207 397 8900

Bobbie Hilliam (NOMAD)

Harry Pardoe

 

 

 

Luther Pendragon

0207 618 9100

Harry Chathli, Claire Norbury, Alexis Gore

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Sir Peter Williams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

20p (Offer price)

 

14,814

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

14,814 Ordinary Shares

 

 

20p per Ordinary Share

 

e)

 

Date of the transaction

 

 

13 February 2017

f)

 

Place of the transaction

 

 

N/a

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Sir Peter Williams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

22.19p

 

35,186

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

35,186 Ordinary Shares

 

 

22.19p per Ordinary Share

 

e)

 

Date of the transaction

 

 

13 February 2017

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Derek Bulmer

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

20p (Offer price)

 

23,934

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

23,934 Ordinary Shares

 

 

20p per Ordinary Share

 

e)

 

Date of the transaction

 

 

13 February 2017

f)

 

Place of the transaction

 

 

N/a

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jerel Whittingham

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

21.45p

 

4,440

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

4,440 Ordinary Shares

 

 

21.45p per Ordinary Share

 

e)

 

Date of the transaction

 

 

14 February 2017

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

About Kromek Group plc

 

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKQDBOBKDNBD
Date   Source Headline
27th Jun 20197:00 amRNSFinal Results
7th May 20197:00 amRNSTrading Update
1st May 20197:00 amRNSSecurity screening contract order expansion
29th Mar 20194:51 pmRNSChange of Adviser
18th Mar 20195:50 pmRNSDirector Dealings Correction
28th Feb 20191:00 pmRNSHolding(s) in Company
28th Feb 20191:00 pmRNSHolding(s) in Company
28th Feb 201912:55 pmRNSHolding(s) in Company
28th Feb 201912:55 pmRNSHolding(s) in Company
28th Feb 201912:50 pmRNSHolding(s) in Company
26th Feb 201912:56 pmRNSDirector Dealings
26th Feb 20197:00 amRNSNuclear security contract with new OEM customer
25th Feb 20191:02 pmRNSResults of General Meeting and Open Offer and TVR
7th Feb 20197:00 amRNSFirm Placing and Open Offer and Notice of GM
28th Jan 20197:00 amRNSKromek Awarded $58m Medical Imaging Contract
14th Jan 20197:00 amRNSInterim Results
18th Dec 20187:00 amRNSNotice of Results
10th Dec 20187:00 amRNSKromek awarded first biological contract by DARPA
19th Nov 20187:00 amRNSFive-year $7.8m baggage screening contract
1st Oct 20185:12 pmRNSResult of AGM and Directorate Change
27th Sep 20187:00 amRNSKromek awarded $1.8m funding from DTRA
7th Sep 20182:57 pmRNSNotice of AGM and Posting of Annual Report
20th Aug 20187:00 amRNSKromek wins two new contracts in medical division
23rd Jul 20187:00 amRNSKromek secures two contracts from US government
17th Jul 20187:00 amRNSKromek radiation detectors used during NATO Summit
2nd Jul 20187:00 amRNSFinal Results
30th May 20187:00 amRNSFive-year contract from existing medical customer
1st May 20187:00 amRNSTrading Update
23rd Apr 20187:00 amRNSAward of Molecular Breast Imaging Device project
12th Mar 20187:00 amRNSAward of $1.6m extension to contract by DARPA
11th Jan 20187:00 amRNSAppointment of Joint Broker
19th Dec 20177:00 amRNSInterim Results
27th Nov 20177:00 amRNSNotice of Results
31st Oct 20174:13 pmRNSTotal Voting Rights
13th Oct 20177:00 amRNSDirector/PDMR Shareholding
10th Oct 20179:50 amRNSDirector/PDMR Shareholding
26th Sep 201712:12 pmRNSResult of AGM
26th Sep 20177:00 amRNSDirectorate Change
19th Sep 20174:43 pmRNSExercise of Options
4th Sep 20177:00 amRNSNew five-year security screening contract
1st Sep 201710:49 amRNSNotice of AGM and Posting of Annual Report
31st Aug 201710:51 amRNSTotal Voting Rights
17th Aug 20177:00 amRNSAward of Five-Year Contract from BMD Customer
10th Jul 201712:00 pmRNSPublication of Annual Report
28th Jun 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSKromek Radiation Detectors Used During Trump Visit
1st Jun 20171:34 pmRNSTotal Voting Rights
2nd May 201712:23 pmRNSHolding(s) in Company
28th Apr 20177:00 amRNSTrading Update
5th Apr 201712:18 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.